AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Hybrigen And Bionomics Announce Drug Target Discovery Alliance.(breast cancer tumor suppressor gene research)
2001 OCT 25 - (NewsRx.com & NewsRx.net) -- Hybrigen Inc. and Bionomics Ltd. (BNO) have signed a letter of intent to negotiate the terms of a collaboration to discover drug targets in breast cancer. The drug target discovery program will be based on genes identified and patented by Bionomics, focused initially on two genes known as TSG18 and BNO1. TGS18 is undergoing study as a breast cancer tumor suppressor gene; BNO1 has been shown to induce programmed cell death in breast cancer cells. Hybrigen will use its proprietary proteomic technologies to discover drug targets that interact with these genes. The two companies will co-own the drug targets developed in this program.
"We are pleased to announce this exciting collaboration with Bionomics, said David Edwards, MD, PhD, president and CEO of Hybrigen. "We are especially pleased to be attacking breast cancer, and we are hopeful our efforts will make a ...
- Hybrigen, Inc. and Bionomics Limited Announce Drug Target Discovery Alliance.
- Press release article from: PR Newswire September 20, 2001 700+ words
...Companies to Focus on Breast Cancer - DALLAS and ADELAIDE...Hybrigen, Inc. and Bionomics Limited (ASX...Bionomics said, "Bionomics is a world-leader...discovery of genes for breast cancer and has filed patent...medical conditions. Bionomics has chosen to ...
- Hybrigen, Inc. and Bionomics Limited Expand Drug Target Discovery Alliance; -...
- Press release article from: PR Newswire January 30, 2002 700+ words
...between Hybrigen and Bionomics follows the initial...identified and patented by Bionomics from its breast cancer project. The two...medical conditions. Bionomics has chosen to concentrate...research in the areas of breast cancer, epilepsy and angiogenesis...
- Bionomics commercialization gaining momentum.
- Newspaper article from: BIOTECH Patent News November 1, 2004 700+ words
...Organizations working with Bionomics in its epilepsy and...exciting results in a breast cancer model from a gene...targeting BNO69, one of Bionomics' proprietary drug...both angiogenesis and breast cancer growth in this model...Rathjen said. Bionomics is a world leader in...
- Bionomics Establishes Neuroscience Research Collaboration With Howard Florey...
- Press release article from: PR Newswire February 25, 2003 700+ words
...the Bank of New York. Bionomics combines its strong genomics...diagnostic applications. Bionomics focuses its research and development activities in breast cancer, epilepsy and angiogenesis...represent large markets for Bionomics-developed products...
- BIONOMICS FORMS NEUROSCIENCE RESEARCH WITH HOWARD F INSTITUTE.
- News wire article from: AsiaPulse News February 25, 2003 700+ words
...the Bank of New York. Bionomics combines its strong genomics...diagnostic applications. Bionomics focuses its research and development activities in breast cancer, epilepsy and angiogenesis...represent large markets for Bionomics-developed products...
- BIONOMICS DEVELOPS MODEL TO ACCELERATE ANGIOGENESIS DRUG.
- News wire article from: AsiaPulse News January 29, 2003 700+ words
...the Bank of New York. Bionomics combines its strong genomics...diagnostic applications. Bionomics focuses its research and development activities in breast cancer, epilepsy and angiogenesis...represent large markets for Bionomics-developed products...
- BIONOMICS & WALTER & ELIZA HALL INSTITUTE DRUG DISCOVERY COLLABORATION.
- News wire article from: AsiaPulse News February 25, 2004 700+ words
...by The Bank of New York. Bionomics combines its strong genomics...diagnostic applications. Bionomics focuses its research and development activities in epilepsy, breast cancer and angiogenesis (a critical...represent large markets for Bionomics-developed products. Importantly...
- BIONOMICS PRESENTS AT BIO CEO & INVESTOR CONFERENCE.
- News wire article from: AsiaPulse News February 27, 2003 700+ words
...the Bank of New York. Bionomics combines its strong genomics...diagnostic applications. Bionomics focuses its research and development activities in breast cancer, epilepsy and angiogenesis...represent large markets for Bionomics-developed products...